Ginkgo Bioworks Holdings (DNA) Change in Account Payables (2020 - 2023)

Ginkgo Bioworks Holdings' Change in Account Payables history runs 4 years deep, the most recent figure standing at -$6.7 million for Q2 2023.

• Quarterly Change in Account Payables rose 57.14% year-over-year to -$6.7 million in Q2 2023, while the trailing twelve-month figure through Jun 2023 was -$18.5 million (down 217.66% YoY) and the FY2025 annual result came in at -$3.0 million, down 162.71% from the prior year.
• Change in Account Payables was -$6.7 million for Q2 2023 at Ginkgo Bioworks Holdings, down from $9.7 million in the prior quarter.
• Across five years, Change in Account Payables topped out at $26.2 million in Q1 2022 and bottomed at -$15.6 million in Q2 2022.
• A 4-year average of -$525363.6 and a median of $516000.0 in 2021 frame the typical range for Change in Account Payables.
• Peak annual rise in Change in Account Payables reached 4987.21% in 2022, while the deepest fall reached 2912.4% in 2022.
• Ginkgo Bioworks Holdings' Change in Account Payables stood at $4.3 million in 2020, then sank by 87.87% to $524000.0 in 2021, then plunged by 2912.4% to -$14.7 million in 2022, then surged by 54.63% to -$6.7 million in 2023.
• Business Quant data shows DNA's Change in Account Payables at -$6.7 million in Q2 2023, $9.7 million in Q1 2023, and -$14.7 million in Q4 2022.